Sector Update: Healthcare Shares Flat Pre-Market; Sarepta Therapeutics Drops 6% as Citi Cuts Rating
Sector Update: Healthcare Shares Flat Pre-Market; Sarepta Therapeutics Drops 6% as Citi Cuts Rating to Sell from Neutral
Why You Should Watch Sarepta Therapeutics Today
Sarepta could be lead the health care sector higher in 2014
3 Simple Rules for Investing in Health Care Stocks
Fool's Rules for investing intelligently in health care
Why UNS Energy, Sarepta Therapeutics, and Zale Are Today's 3 Best Stocks
The S&P 500 sinks for a third straight session following a dismal initial weekly jobless claims report, but that didn't stop UNS Energy, Sarepta Therapeutics, or Zale from advancing by double digits.